Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Number of items: 4.

Noble, Simon I., Nelson, Annmarie, Fitzmaurice, David, Bekkers, Marie-Jet, Baillie, Jessica, Sivell, Stephanie, Canham, Joanna, Smith, Joanna D., Casbard, Angela, Cohen, Ander, Cohen, David, Evans, Jessica, Fletcher, Kate, Johnson, Miriam, Maraveyas, Anthony, Prout, Hayley and Hood, Kerenza 2015. A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment 19 (83) , pp. 1-94. 10.3310/hta19830

Geldart, Thomas, Chester, John, Casbard, Angela, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna, Cowles, Robert, Evans, Jessica and Griffiths, Gareth 2015. SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European Urology 67 (4) , pp. 599-602. 10.1016/j.eururo.2014.11.003

Noble, Simon, Smith, Joanna D., Baillie, Jessica, Baglin, T., Griffiths, Gareth O., Casbard, Angela, Cohen, Deborah, Fitzmaurice, D., Hood, Kerenza, Rose, P., Cohen, A., Johnson, Miriam, Maraveyas, A., Bell, John, Toone, H. and Nelson, Annmarie 2014. ALICAT: Anticoagulation length in cancer associated thrombosis - a mixed-methods feasibility study. Thrombosis Research 133 (Supp 2) , S220-S220. 10.1016/S0049-3848(14)50032-1

Smith, Joanna D., Baillie, Jessica, Baglin, Trevor, Griffiths, Gareth O., Casbard, Angela C., Cohen, David, Fitzmaurice, David A., Hood, Kerenza, Rose, Peter, Cohen, Alexander T., Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie and Noble, Simon Ian Robert 2014. A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study. Trials 15 (1) , 122. 10.1186/1745-6215-15-122

This list was generated on Sun Oct 2 09:08:24 2022 BST.